A New Viscous Budesonide Formulation for the Treatment of Eosinophilic Esophagitis in Children: A Preliminary Experience and Review of the Literature
Eosinophilic esophagitis (EoE) is a chronic disease, characterized clinically by esophageal disfunction. Topical corticosteroids (tCS), predominantly fluticasone and budesonide, are considered the effective first line treatment, as well as an option of maintenance therapy in EoE. The way that tCS ar...
Main Authors: | Joanna Warzecha, Marcin Dziekiewicz, Alicja Bieńkowska-Tokarczyk, Maciej Małecki, Aleksandra Banaszkiewicz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/22/6730 |
Similar Items
-
Comment on Casiraghi et al. “Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis” 2020, <i>12</i>, 211
by: Eyal Zur
Published: (2020-08-01) -
Formulations of Topical Steroids in Eosinophilic Esophagitis—Current Treatment and Emerging Possibilities
by: Adam Główczewski, et al.
Published: (2022-03-01) -
Efficacy of Topical Corticosteroid Monotherapy in Inducing and Maintaining Clinical and Histologic Remission in Adolescent and Adult Patients with Eosinophilic Esophagitis: a Systematic Review and Meta-Analysis
by: A. A. Makushina, et al.
Published: (2022-12-01) -
Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis
by: Antonella Casiraghi, et al.
Published: (2020-03-01) -
Clinical Guidelines of the Russian Gastroenterological Association on the Diagnostics and Treatment of Eosinophilic Esophagitis
by: V. T. Ivashkin, et al.
Published: (2019-01-01)